Literature DB >> 2978680

Adverse effects of corticosteroids: I. Topical and intralesional.

R J Coskey1.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 2978680     DOI: 10.1016/0738-081x(86)90019-2

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  5 in total

Review 1.  Managing Mild-to-Moderate Psoriasis in Elderly Patients: Role of Topical Treatments.

Authors:  Joseph G Kamel; Paul S Yamauchi
Journal:  Drugs Aging       Date:  2017-08       Impact factor: 3.923

Review 2.  Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.

Authors:  Gil Yosipovitch; Mark B Y Tang
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome, gene 1) selectively inhibits transactivation but not transrepression mediated by the glucocorticoid receptor in a LXXLL-dependent manner.

Authors:  Junguo Zhou; Robert H Oakley; John A Cidlowski
Journal:  Mol Endocrinol       Date:  2008-04-16

4.  Intralesional Treatment With 5-Fluorouracil and Steroid Improves Allergic Contact Dermatitis Without Causing Skin Atrophy and Rebound Lesions.

Authors:  Xiangming Chen; Guojiang Wang; Qingwen Zeng; Haiqing Zhang; Yang Hu; Aihua Yu; Ting Li
Journal:  Dermatitis       Date:  2017 May/Jun       Impact factor: 4.845

Review 5.  Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons.

Authors:  Anne Sofie Frølunde; Jacob Pontoppidan Thyssen; Mette Deleuran; Christian Vestergaard
Journal:  Am J Clin Dermatol       Date:  2021-07-28       Impact factor: 7.403

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.